Periodic Reporting for period 3 - MYCure (Innovative cancer therapy through Myc inhibition: taking OMO-103 to market)
Project: MYCure
Updated at: 29-04-2024
Project: MYCure
Updated at: 29-04-2024
Project: MYCure
Updated at: 29-04-2024
Project: MYCure
Updated at: 29-04-2024
Project: MYCure
Updated at: 29-04-2024
Project: MYCure
Updated at: 29-04-2024
Project: MYCure
Updated at: 29-04-2024
Project: MYCure
Updated at: 29-04-2024
Project: MYCure
Updated at: 29-04-2024
Project: MYCure
Updated at: 29-04-2024
Project: MYCure
Updated at: 29-04-2024
Project: MYCure
Updated at: 29-04-2024
Project: MYCure
Updated at: 29-04-2024
Project: MYCure
Updated at: 29-04-2024
Project: MYCure
Updated at: 29-04-2024
Project: MYCure
Updated at: 29-04-2024
Project: MYCure
Updated at: 29-04-2024
Project: MYCure
Updated at: 29-04-2024
Project: MYCure
Updated at: 29-04-2024
Project: MYCure
Updated at: 29-04-2024